TRINITY BIOTECH PLC Cost Of Sales
TRINITY BIOTECH PLC (TRIB) reported Cost Of Sales of $40.11 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-05-16.
Financial Statements › Expense Statement › Cost of Sales
ifrs-full:CostOfSales · last filed 2025-05-16
- TRINITY BIOTECH PLC cost of sales for the quarter ending 2018-06-30 was $14.19M, a 2.97% decline year-over-year.
- TRINITY BIOTECH PLC cost of sales for the quarter ending 2017-06-30 was $14.63M.
| Period end | Cost Of Sales 3 month | Cost Of Sales 6 month | Cost Of Sales 12 month | Cost Of Sales 12 month as first filed |
|---|---|---|---|---|
| 2024-12-31 | $40.11M 20-F · filed 2025-05-16 | |||
| 2024-06-30 | $19.29M 6-K · filed 2024-10-02 | |||
| 2023-12-31 | $37.38M 20-F · filed 2025-05-16 | |||
| 2023-06-30 | $18.12M 6-K · filed 2024-10-02 | |||
| 2022-12-31 | $45.25M 20-F · filed 2025-05-16 | $52.73M 20-F · filed 2023-05-16 | ||
| 2022-06-30 | $23.44M 6-K · filed 2022-11-15 | |||
| 2021-12-31 | $47.70M 20-F · filed 2024-04-30 | $54.89M 20-F · filed 2022-05-02 | ||
| 2021-06-30 | $29.50M 6-K · filed 2022-11-15 | |||
| 2020-12-31 | $53.40M 20-F · filed 2023-05-16 | |||
| 2019-12-31 | $52.31M 20-F · filed 2022-05-02 | |||
| 2018-12-31 | $55.59M 20-F · filed 2021-04-30 | |||
| 2018-06-30 | $14.19M 6-K · filed 2018-07-23 | $27.57M 6-K · filed 2018-07-23 | ||
| 2017-12-31 | $57.25M 20-F · filed 2020-06-15 | |||
| 2017-06-30 | $14.63M 6-K · filed 2018-07-23 | $28.27M 6-K · filed 2018-07-23 | ||
| 2016-12-31 | $56.13M 20-F · filed 2019-05-14 | |||
| 2015-12-31 | $53.68M 20-F · filed 2018-04-20 |